Soung-min Lee
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Potential of histone deacetylase 6 inhibitors in alleviating chemotherapy-induced peripheral neuropathy.
Journal: The Korean journal of pain
Published: October 30, 2024
Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis.
Journal: International immunopharmacology
Published: February 05, 2024
Priming Mesenchymal Stem/Stromal Cells with a Combination of a Low Dose of IFN-γ and Bortezomib Results in Potent Suppression of Pathogenic Th17 Immunity Through the IDO1-AHR Axis.
Journal: Stem cells (Dayton, Ohio)
Published: March 02, 2022
Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-κB Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine Colitis.
Journal: Inflammatory bowel diseases
Published: August 09, 2019
Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 05, 2017
Therapeutic activity of the histone deacetylase inhibitor SB939 on renal fibrosis.
Journal: International immunopharmacology
Published: August 09, 2016
Effect of upregulated TLR2 expression from G-CSF-mobilized donor grafts on acute graft-versus-host disease.
Journal: International immunopharmacology
Published: May 30, 2015
Effects of topical chondrocyte-derived extracellular matrix treatment on corneal wound healing, following an alkali burn injury.
Journal: Molecular medicine reports
Published: January 27, 2014
The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation.
Journal: International immunopharmacology
Published: May 07, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026